These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19995328)

  • 21. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
    Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
    FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain.
    Jaroniec CP; Kaufman JD; Stahl SJ; Viard M; Blumenthal R; Wingfield PT; Bax A
    Biochemistry; 2005 Dec; 44(49):16167-80. PubMed ID: 16331977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
    Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
    J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical evidence of two docking sites of the carboxyl heptad repeat region within the amino heptad repeat region of gp41 of human immunodeficiency virus type 1.
    Chang DK; Hsu CS
    Antiviral Res; 2007 Apr; 74(1):51-8. PubMed ID: 17258818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
    Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
    J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
    Wexler-Cohen Y; Sackett K; Shai Y
    Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide.
    Noah E; Biron Z; Naider F; Arshava B; Anglister J
    Biochemistry; 2008 Jul; 47(26):6782-92. PubMed ID: 18540633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
    Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
    J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively.
    Shnaper S; Sackett K; Gallo SA; Blumenthal R; Shai Y
    J Biol Chem; 2004 Apr; 279(18):18526-34. PubMed ID: 14981088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Lawless MK; Barney S; Guthrie KI; Bucy TB; Petteway SR; Merutka G
    Biochemistry; 1996 Oct; 35(42):13697-708. PubMed ID: 8885850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformation of trimeric envelope glycoproteins: the CD4-dependent membrane fusion mechanism of HIV-1.
    Yingliang W; Hong Y; Zhijian C; Wenxin L
    J Biomol Struct Dyn; 2007 Aug; 25(1):1-9. PubMed ID: 17676933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S; Debnath AK
    Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled-coil domain regulates 6-helical bundle formation.
    Zhao L; Hu ZW; Tong P; Chen YX; Zhao YF; Li YM
    Bioorg Med Chem Lett; 2013 May; 23(9):2727-32. PubMed ID: 23522564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.